molecule-image-3

Medicinal Chemistry Powered by Machine Learning

PostEra is building an AI-first biotech. We use Proton, our AI platform for medicinal chemistry, to discover and develop new medicines for patients.

molecule-image

molecule-image-2

About PostEra

How is PostEra using Proton to address the challenges of drug discovery?

Read More

Drug Discovery

What medicines are we working on?

Read More

Meet the Team

AaronMorris[1]

Aaron Morris

CEO

AlphaLee[1]

Alpha Lee

CSO

Matt

Matthew Robinson

CTO

Emily Hanan Medicinal Chemist

Emily Hanan

VP Drug Discovery

Ricardo_Azziz

Ricardo Azziz

Acting Chief Medical Officer

Our Drug Discovery Partners

molecule_bg_team

molecule-image

In the News

Sep 2026

Merck KGaA Acquires PostEra’s Fertility Programs

Jan 2025

PostEra announces expansion to $610M in their AI drug discovery collaboration with Pfizer

endpoint

Mar 2024

PostEra provides update on progress of the Pfizer-partnered AI Lab